January 25, 2016

March 19, 2014

Pennsylvania-based heart monitoring company BioTelemetry Inc. agreed to pay $6.4 million to resolve allegations its subsidiary CardioNet violated the False Claims Act by overbilling Medicare and other federal health programs for Mobile Cardiac Outpatient Telemetry services when those services were not reasonable or medically necessary.  DOJ

*     *     *

If you would like more information or would like to speak to a member of Constantine Cannon’s whistleblower lawyer team, please click here.